Grossi Federico

CIK 00017206342 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001720634

Recent Transactions

50 trades

Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2025-01-06+150,000→ 150,000 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-05$48.79/sh−2,500→ 94,884 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-12-01$49.93/sh−2,500→ 97,384 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-11-01$60.83/sh−2,500→ 99,884 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-10-03$66.69/sh−2,500→ 102,384 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-09-01$60.30/sh−2,500→ 104,884 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-08-01$55.99/sh−2,500→ 107,384 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-06-01$41.78/sh−2,500→ 109,561 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-05-02$43.56/sh−2,500→ 112,061 total
Other
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-04-21−11,250→ 0 total
Other
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-21−1,875→ 114,561 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-03-15$39.57/sh−375→ 116,436 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-03-15$4.31/sh+7,000→ 116,811 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-03-15−7,000→ 50,723 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-03-01$43.53/sh−375→ 109,811 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-02-23−4,100→ 57,723 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-23$4.31/sh+4,100→ 110,186 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-15$45.43/sh−375→ 106,086 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-14$4.31/sh+3,600→ 106,461 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-02-14−3,600→ 61,823 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-10$47.12/sh−705→ 102,861 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-01$40.58/sh−375→ 103,566 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-28$38.59/sh−650→ 103,941 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-21+26,051→ 104,591 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-21+36,951→ 36,951 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-14$40.56/sh−375→ 78,540 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-14−3,400→ 65,423 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-14$4.31/sh+3,400→ 78,915 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-12$4.31/sh+1,500→ 75,515 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-12$3.76/sh+3,661→ 74,015 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-12−1,500→ 68,823 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-12−3,661→ 0 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-03$47.31/sh−375→ 70,354 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-12-15$42.88/sh−375→ 70,729 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-12-08−7,000→ 3,661 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-12-08$3.76/sh+7,000→ 71,104 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-12-01$42.40/sh−375→ 64,104 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-11-15$43.50/sh−625→ 64,479 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-11-01$30.70/sh−625→ 64,805 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-10-14$34.57/sh−750→ 65,430 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-10-01$33.26/sh−750→ 66,180 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-09-28$3.76/sh+4,000→ 66,930 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-09-28−4,000→ 10,661 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-08-02$63.99/sh−250→ 62,930 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-07-14$64.68/sh−500→ 63,180 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-07-08$65.68/sh−250→ 63,680 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-06-28$3.76/sh+9,000→ 63,930 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-06-28−9,000→ 14,661 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-06-14$61.84/sh−500→ 54,930 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-05-14$45.39/sh−500→ 55,430 total

Companies

Recent Filings

Address

C/O UNITY BIOTECHNOLOGY, INC. 285 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov